Targeting FGFR in intrahepatic cholangiocarcinoma [iCCA]: leading the way for precision medicine in biliary tract cancer [BTC]?
Expert Opinion on Investigational Drugs | March 6, 2021 | Volume: 30 | Issue: 4 | Pages: 463-477
10.1080/13543784.2021.1900821